» Articles » PMID: 36410698

Effect of Modification of Polystyrene Nanoparticles with Different Bile Acids on Their Oral Transport

Overview
Journal Nanomedicine
Publisher Elsevier
Date 2022 Nov 21
PMID 36410698
Authors
Affiliations
Soon will be listed here.
Abstract

Bile acid-modified nanomedicine is a promising strategy to improve oral bioavailability. However, the efficiencies of different bile acids have not been clarified. To clarify this issue, deoxycholic acid (DCA) and cholic acid (CA) and glycocholic acid (GCA) were conjugated to carboxylated polystyrene nanoparticle (CPN). The endocytosis, intracellular and transcellular transport among the NPs were compared in Caco-2 cells, and their oral pharmacokinetics profiles were studied in C57BL/6 J mice. It was found that DCPN demonstrated higher uptake and transcytosis rate. With modification by different bile acids, the transport pathways of the NPs were altered. In mice, GCPN showed the highest absorption speed and oral bioavailability. It was found that the synergic effect of hydrophobicity and ASBT affinity might lead to the difference between in vitro and in vivo transport. This study will build a basis for the rational design of bile acid-modified nanomedicines.

Citing Articles

Polyzwitterion-branched polycholic acid nanocarriers based oral delivery insulin for long-term glucose and metabolic regulation in diabetes mellitus.

Zhang W, Wang Y, Zhang X, Zhang Y, Yu W, Tang H J Nanobiotechnology. 2025; 23(1):133.

PMID: 39987096 PMC: 11846306. DOI: 10.1186/s12951-025-03190-8.

References
1.
Foroozandeh P, Abdul Aziz A . Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles. Nanoscale Res Lett. 2018; 13(1):339. PMC: 6202307. DOI: 10.1186/s11671-018-2728-6. View

2.
Park J, Choi J, Kim K, Byun Y . Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex. Biomaterials. 2017; 147:145-154. DOI: 10.1016/j.biomaterials.2017.09.022. View

3.
Kim K, Suzuki K, Cho H, Youn Y, Bae Y . Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport. ACS Nano. 2018; 12(9):8893-8900. PMC: 6377080. DOI: 10.1021/acsnano.8b04315. View

4.
Kim K, Suzuki K, Cho H, Bae Y . Selected Factors Affecting Oral Bioavailability of Nanoparticles Surface-Conjugated with Glycocholic Acid Intestinal Lymphatic Pathway. Mol Pharm. 2020; 17(11):4346-4353. DOI: 10.1021/acs.molpharmaceut.0c00764. View

5.
Shen L, Weber C, Raleigh D, Yu D, Turner J . Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol. 2010; 73:283-309. PMC: 4655434. DOI: 10.1146/annurev-physiol-012110-142150. View